(Q53500104)

14 May 2018

title

Etoposide, 6-thioguanine and idarubicin, an oral combination regimen (ETI) for the induction treatment of acute leukemia. (English)

1 reference

14 May 2018

1 reference

1 reference

Ruutu T

1

1 reference

14 May 2018

Elonen E

series ordinal

2

1 reference

14 May 2018

publication date

1 March 1991

1 reference

14 May 2018

published in

Hematological Oncology

1 reference

14 May 2018

volume

9

1 reference

14 May 2018

issue

2

1 reference

14 May 2018

page(s)

87-92

1 reference

14 May 2018

Pharmacokinetics of idarubicin (4-demethoxydaunorubicin; IMI-30; NSC 256439) following intravenous and oral administration in patients with advanced cancer

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090204

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090204

7 January 2021

The clinical pharmacology of etoposide and teniposide

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090204

7 January 2021

Treatment of acute myeloid leukemia in elderly patients with oral idarubicin as a single agent

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090204

7 January 2021

Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090204

7 January 2021

Oral idarubicin in adult acute leukemia: a preliminary experience

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090204

7 January 2021

Oral idarubicin in the treatment of acute myelogenous leukaemia and the blast phase of chronic myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090204

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090204

7 January 2021

Intensive treatment of acute leukemia in adults 70 years of age and older

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900090204

7 January 2021

Identifiers

DOI

10.1002/HON.2900090204

1 reference

14 May 2018

1 reference

14 May 2018